SOX9 and Sjogren syndrome: in the Intestinal tissues of patients with inflammatory bowel disease (IBD), including Crohn’s disease (Kobayashi et al., 2024; Zhuang et al., 2022), and as well as in conditions such as Sjögren’s syndrome abnormalities in SOX9 expression are frequently noted (Xiang et al., 2023).